本頁面由Tiger Trade Technology Pte. Ltd.提供服務

PMV Pharmaceuticals

1.31
-0.0400-2.96%
盤後1.30-0.0066-0.50%16:10 EDT
成交量:27.34萬
成交額:36.37萬
市值:6,970.71萬
市盈率:-0.89
高:1.37
開:1.35
低:1.31
收:1.35
52周最高:1.88
52周最低:0.8100
股本:5,321.15萬
流通股本:3,620.46萬
量比:0.54
換手率:0.76%
股息:- -
股息率:- -
每股收益(TTM):-1.4800
每股收益(LYR):-1.4800
淨資產收益率:-55.37%
總資產收益率:-35.00%
市淨率:0.67
市盈率(LYR):-0.89

資料載入中...

2021/05/07

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/04/06

重要事件披露

8-K - Current report
2021/03/03

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/03/03

重要事件披露

8-K - Current report
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/11/13

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/11/13

重要事件披露

8-K - Current report
2020/10/05

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2020/10/05

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/09/30

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/09/29

重要事件披露

8-K - Current report
2020/09/28

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2020/09/24

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2020/09/21

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2020/09/04

招股説明書

S-1 - General form for registration of securities under the Securities Act of 1933